These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21348584)

  • 21. Pulmonary vasculitis.
    Burns A
    Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):389-92. PubMed ID: 9509040
    [No Abstract]   [Full Text] [Related]  

  • 22. Pulmonary manifestations of primary Sjögren's syndrome.
    Parke AL
    Rheum Dis Clin North Am; 2008 Nov; 34(4):907-20, viii. PubMed ID: 18984411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic Resonance Imaging-Confirmed Pleuritis in Systemic Lupus Erythematosus-Associated Shrinking Lung Syndrome.
    Nemec M; Pradella M; Jahn K; Tamm M; Walker UA
    Arthritis Rheumatol; 2015 Jul; 67(7):1880. PubMed ID: 25833740
    [No Abstract]   [Full Text] [Related]  

  • 24. Sjögren's syndrome in dermatology.
    Fox RI; Liu AY
    Clin Dermatol; 2006; 24(5):393-413. PubMed ID: 16966020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shrinking lung syndrome in systemic lupus erythematosus and Sjogren's syndrome.
    Singh R; Huang W; Menon Y; Espinoza LR
    J Clin Rheumatol; 2002 Dec; 8(6):340-5. PubMed ID: 17041405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
    De Jesus A; Talal N
    Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shrinking lung syndrome in pregnancy complicated by antiphospholipid antibody syndrome.
    Meena M; DeStephano CC; Watson WJ; Brost BC
    Obstet Gynecol; 2011 Feb; 117(2 Pt 2):506-508. PubMed ID: 21252806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restrictive lung disease due to diaphragmatic dysfunction in systemic lupus erythematosus. Two case reports.
    Elkayam O; Segal R; Caspi D; Yaron M; Greif Y
    Clin Exp Rheumatol; 1992; 10(3):267-9. PubMed ID: 1582072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diaphragm strength in acute systemic lupus erythematosus in a patient with paradoxical abdominal motion and reduced lung volumes.
    Hawkins P; Davison AG; Dasgupta B; Moxham J
    Thorax; 2001 Apr; 56(4):329-30. PubMed ID: 11254829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunosuppressive therapy in autoimmune diseases].
    Schwarz-Eywill M
    Z Arztl Fortbild Qualitatssich; 1999 Mar; 93(2):93-100. PubMed ID: 10355057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collagen vascular diseases.
    Corley DE; Winterbauer RH
    Semin Respir Infect; 1995 Jun; 10(2):78-85. PubMed ID: 7569402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The lung as a reflection of internal medicine diseases].
    Schwery S; Siegenthaler W
    Z Gesamte Inn Med; 1992 Apr; 47(4):137-47. PubMed ID: 1595299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary disease in systemic lupus erythematosus and the antiphospholpid syndrome.
    Paran D; Fireman E; Elkayam O
    Autoimmun Rev; 2004 Jan; 3(1):70-5. PubMed ID: 14871652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary amyloidosis in Sjögren's syndrome: a rare diagnosis for nodular lung lesions.
    Rodrigues K; Neves FS; Stoeterau KB; Werner Castro GR; Nobre LF; Zimmermann AF; Pereira IA
    Int J Rheum Dis; 2009 Dec; 12(4):358-60. PubMed ID: 20374376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sjogren's syndrome].
    Rasković S; Bogić M; Perić-Popadić A; Tomić-Spirić V
    Srp Arh Celok Lek; 1997; 125(1-2):54-8. PubMed ID: 17974357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Shrinking lung syndrome and systemic auto-immune disease].
    Branger S; Schleinitz N; Gayet S; Veit V; Kaplanski G; Badier M; Magnan A; Harlé JR
    Rev Med Interne; 2004 Jan; 25(1):83-90. PubMed ID: 14736565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory manifestations of systemic lupus erythematosus: old and new concepts.
    Pego-Reigosa JM; Medeiros DA; Isenberg DA
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):469-80. PubMed ID: 19591778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The overlap of Sjögren's syndrome with other systemic autoimmune diseases.
    Ramos-Casals M; Brito-Zerón P; Font J
    Semin Arthritis Rheum; 2007 Feb; 36(4):246-55. PubMed ID: 16996579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D; DeClerck LS; Bridts CH; Stevens WJ
    In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.